Studies & Trials

Please consult www.clinicaltrials.gov under the name TheraSphere for additional information.

News Releases

• Nordion Awards Contract for Phase III Clinical Trials to Theorem Clinical Research (Jun. 16, 2011)
• Nordion Reports TheraSphere^® Phase II Clinical Trial Results at Society of Interventional Radiology (Mar. 28, 2011)
• Nordion announces Phase III clinical trial to evaluate TheraSphere^® in treatment of unresectable hepatocellular carcinoma (Mar. 23, 2011)
• Nordion announces Phase III clinical trial to evaluate TheraSphere^® for liver metastases in colorectal cancer patients (Mar. 23, 2011)

Ongoing Studies

TheraSphere for the Treatment of Liver Metastases
An open label trial of TheraSphere in patients with liver metastases from primary colorectal cancer, neuroendocrine cancer or non-colorectal/non-neuroendocrine cancer. This study is on-going, but is no longer recruiting patients.